Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jude

Showing results (211-220 of 221) with videos related to

Pageof 23
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 27, 2012
Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout miceKamal K E Gadalla, Mark E S Bailey, Rosemary C Spike, et al.
Science Translational Medicine|December 21, 2012
Long-term follow-up after gene therapy for canavan diseasePaola Leone, David Shera, Scott W J McPhee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2011
Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vectorDawn E Bowles, Scott W J McPhee, Chengwen Li, et al.
Human Gene Therapy|November 25, 2014
Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trialPaul E Monahan, Junjiang Sun, Tong Gui, et al.
Journal of the American College of Cardiology|September 30, 2017
Protein Phosphatase Inhibitor-1 Gene Therapy in a Swine Model of Nonischemic Heart FailureShin Watanabe, Kiyotake Ishikawa, Kenneth Fish, et al.
The New England Journal of Medicine|October 8, 2010
Dystrophin immunity in Duchenne's muscular dystrophyJerry R Mendell, Katherine Campbell, Louise Rodino-Klapac, et al.
Blood|October 17, 2020
BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expressionBarbara A Konkle, Christopher E Walsh, Miguel A Escobar, et al.
Journal of Virology|June 14, 2013
Capsid antibodies to different adeno-associated virus serotypes bind common regionsBrittney L Gurda, Michael A DiMattia, Edward B Miller, et al.
Nature Medicine|October 21, 2025
Cardiotropic AAV gene therapy for heart failure: a phase 1 trialTimothy D Henry, Eugene S Chung, Monica Alvisi, et al.
Human Gene Therapy|March 23, 2013
Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012Marina O'Reilly, Donald B Kohn, Jeffrey Bartlett, et al.
Pageof 23

Showing results (211-220 of 221) with videos related to

Sort By:
Pageof 23
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 27, 2012
Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout miceKamal K E Gadalla, Mark E S Bailey, Rosemary C Spike, et al.
Science Translational Medicine|December 21, 2012
Long-term follow-up after gene therapy for canavan diseasePaola Leone, David Shera, Scott W J McPhee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2011
Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vectorDawn E Bowles, Scott W J McPhee, Chengwen Li, et al.
Human Gene Therapy|November 25, 2014
Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trialPaul E Monahan, Junjiang Sun, Tong Gui, et al.
Journal of the American College of Cardiology|September 30, 2017
Protein Phosphatase Inhibitor-1 Gene Therapy in a Swine Model of Nonischemic Heart FailureShin Watanabe, Kiyotake Ishikawa, Kenneth Fish, et al.
The New England Journal of Medicine|October 8, 2010
Dystrophin immunity in Duchenne's muscular dystrophyJerry R Mendell, Katherine Campbell, Louise Rodino-Klapac, et al.
Blood|October 17, 2020
BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expressionBarbara A Konkle, Christopher E Walsh, Miguel A Escobar, et al.
Journal of Virology|June 14, 2013
Capsid antibodies to different adeno-associated virus serotypes bind common regionsBrittney L Gurda, Michael A DiMattia, Edward B Miller, et al.
Nature Medicine|October 21, 2025
Cardiotropic AAV gene therapy for heart failure: a phase 1 trialTimothy D Henry, Eugene S Chung, Monica Alvisi, et al.
Human Gene Therapy|March 23, 2013
Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012Marina O'Reilly, Donald B Kohn, Jeffrey Bartlett, et al.
Pageof 23